Search hospitals > New Hampshire > Concord
New Hampshire Oncology Hematology PA-Concord
Claim this profileConcord, New Hampshire 03301
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
107 reported clinical trials
1 medical researcher
Summary
New Hampshire Oncology Hematology PA-Concord is a medical facility located in Concord, New Hampshire. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. New Hampshire Oncology Hematology PA-Concord is involved with conducting 107 clinical trials across 145 conditions. There are 1 research doctors associated with this hospital, such as Douglas Weckstein, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Clinical Trials running at New Hampshire Oncology Hematology PA-Concord
Breast Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Anal Squamous Cell Carcinoma
Rectal Cancer
Bladder Cancer
Prostate Adenocarcinoma
Squamous Cell Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at New Hampshire Oncology Hematology PA-Concord?
New Hampshire Oncology Hematology PA-Concord is a medical facility located in Concord, New Hampshire. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. New Hampshire Oncology Hematology PA-Concord is involved with conducting 107 clinical trials across 145 conditions. There are 1 research doctors associated with this hospital, such as Douglas Weckstein, MD.